Hangue Park | Neuroprosthetics | Best Researcher Award

Prof. Hangue Park | Neuroprosthetics | Best Researcher Award  🏆

Associate professor at  Sungkyunkwan University,South Korea🎓

Dr. Hangue Park is a prominent academic and researcher specializing in neuroprosthetics, multisensory integration, motor learning, rehabilitation, and human augmentation. Currently serving as an Associate Professor at the Department of Biomedical Engineering and the Department of Intelligent Precision Healthcare Convergence at Sungkyunkwan University in South Korea, Dr. Park also holds adjunct faculty positions at Texas A&M University. His research focuses on developing innovative neuroprosthetic technologies, brain-machine interfaces, and rehabilitation systems to improve the lives of patients with neurological impairments. Through his leadership of the Integrated NeuroProsthesis Lab, Dr. Park is pushing the boundaries of neural engineering to achieve advanced human augmentation and neuroprosthetic applications. He has an interdisciplinary background that merges electrical engineering, biomedical engineering, and neuroscience to address real-world challenges in medical technology.

 

Professional Profile 

Education 🎓:

Dr. Park completed his Ph.D. in Electrical and Computer Engineering with a minor in Biomedical Engineering from Georgia Institute of Technology in 2017, where his dissertation focused on gait optimization and real-time sensory feedback systems for amputee cats. He earned his Master’s degree in Electrical and Computer Engineering from Seoul National University in 2008, focusing on the design of wireless capsule endoscopy systems. Dr. Park received his Bachelor’s degree in Electrical and Computer Engineering, graduating Cum Laude, from Seoul National University in 2006. His advanced studies reflect his strong foundation in both engineering and medical technologies, equipping him to bridge the gap between technology and human health.

 

Work Experience 💼:

Dr. Park’s work experience spans academia, research, and industry. He is currently an Associate Professor at Sungkyunkwan University and has been affiliated with Texas A&M University as an adjunct faculty member since 2017. He was previously an Assistant Professor at Texas A&M University in the Department of Electrical and Computer Engineering (2017-2022). Prior to his academic career, Dr. Park worked at Samsung Electronics, where he contributed to the design of digital RF transceivers and tunable components for cellphone applications (2008-2010). Additionally, he spent time at Samsung Advanced Institute of Technology working on cutting-edge RF and oscillator designs. His industry experience informs his research, allowing him to bring practical, innovative solutions to complex biomedical challenges.

 

Skills 🔍

Dr. Park possesses a diverse skill set that bridges engineering, neuroscience, and medical technology. His expertise includes neuroprosthetics, motor learning and rehabilitation, human augmentation, and neural interfaces. He is skilled in developing neuromorphic circuits and bidirectional neuroprostheses, and he uses advanced computational and experimental techniques to optimize neural feedback systems. His ability to integrate electrical engineering with neuroscience allows him to approach complex problems from a multidisciplinary perspective, making him a leader in his field. He is also adept in circuit design, biomedical instrumentation, and the development of medical devices aimed at improving patients’ quality of life.

 

Awards and Honors 🏆

Dr. Park has received numerous accolades for his work in biomedical engineering and neuroscience. He was nominated for the COE TEES Young Faculty Fellow Award at Texas A&M University in 2022. He has also won several prestigious research awards, such as the Outstanding Research Award from the Association of Korean Neuroscientists in 2016 and the SRI Spinal Cord Injury Research Writing Prize in 2022. His poster presentations have earned top honors at several conferences, including first-place awards at Texas A&M Student Research Week and the Mission Connect Symposium. Dr. Park’s contributions have been recognized by major scientific organizations, and his work continues to impact both the academic community and industry.

 

🤝 Memberships:

Dr. Park is an active member of several professional organizations. He is a member of the IEEE Circuits and Systems Society, the IEEE Engineering in Medicine and Biology Society, and the Society for Neuroscience (SfN). He is also affiliated with the Dysphagia Research Society (DRS) and the American Heart Association (AHA). His engagement with these societies enables him to stay at the forefront of advancements in neuroprosthetics, biomedical engineering, and neuroscience. Additionally, Dr. Park serves on the editorial boards of leading journals such as IEEE Transactions on Circuits and Systems II and Frontiers in Neuroscience.

 

Teaching Experience 👩‍🏫:

Dr. Park has extensive teaching experience, primarily in the fields of biomedical engineering and electrical engineering. He currently teaches at Sungkyunkwan University and Texas A&M University, where he has mentored numerous graduate students in both research and clinical applications. He has served as the advisor and committee chair for a large number of MS and PhD students, guiding them in projects related to neuroprosthetics, neural interfaces, and rehabilitation technology. His commitment to teaching is also reflected in his leadership roles in various academic committees, including the Graduate Studies Committee at Texas A&M University.

 

Research Focus 🔬:

Dr. Park’s research focuses on the development of advanced neuroprosthetic devices and systems to restore lost sensory and motor functions in patients with neurological impairments. He specializes in bidirectional neuroprosthesis, multisensory integration, motor learning, and the use of neural intelligence to enhance human capability. His work includes the development of systems for brain-machine interfaces and rehabilitation technologies aimed at improving the mobility and autonomy of individuals with spinal cord injuries or amputations. Dr. Park is also interested in the potential of human augmentation and the integration of neural intelligence to create superhuman capabilities. His research combines expertise in neuromorphic circuits, neural prosthetics, and motor control to develop practical, impactful solutions for patient rehabilitation.

Conclusion 

In conclusion, Dr. Hangue Park’s research exemplifies the qualities of an ideal candidate for the Best Researcher Award. His interdisciplinary expertise, pioneering work in neuroprosthetics, and commitment to improving patient outcomes make him a leader in the field. Despite potential challenges related to real-world implementation and ethical considerations, Dr. Park’s groundbreaking contributions to science and technology position him as an outstanding researcher whose work will continue to influence and inspire the field of biomedical engineering for years to come. His combination of innovation, academic achievement, and dedication to improving human health makes him highly deserving of this prestigious award.

📚 Publilcation

  • Underground Metal Pipeline Localization Using Low-cost Wireless Magnetic Sensors Mounted on an Excavator
  • Palatal Electrotactile Display Outperforms Visual Display in Tongue Motor Learning
  • Pinching Force Changes by Modulating the Interaction Gain Over the Fingertip
  • Challenges, Tasks, and Opportunities in Teleoperation of Excavator Toward Human-in-the-loop Construction Automation
  • Forehead Tactile Hallucination Is Augmented by the Perceived Risk and Accompanies Increase of Forehead Tactile Sensitivity
  • A CNN-based Method to Reconstruct 3-D Spine Surfaces from US Images in Vivo

Ioannis Charalampopoulos | Neuroscience | Best Researcher Award

Prof. Ioannis Charalampopoulos
| Neuroscience | Best Researcher Award 🏆

Professor of Pharmacology at Medical School, University of Crete,Greece🎓

Dr. Ioannis Charalampopoulos is a distinguished Professor of Pharmacology at the University of Crete’s Medical School and a Group Leader at the Institute of Molecular Biology and Biotechnology (IMBB), Foundation of Research and Technology, Hellas (FORTH). With a focus on neuropharmacology and molecular biology, his research has contributed significantly to the study of neurodegenerative diseases, brain development, and regeneration. He has an extensive academic and research career spanning over two decades, with notable achievements in the development of novel therapeutic strategies for Alzheimer’s and spinal cord injury.

 

Professional Profile 

Education 🎓:

  • 2021-present: Director of the Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, Medical School, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden
  • 2001-2005: PhD in Pharmacology, Medical School, University of Crete
  • 1998-2000: Master of Science in Neurosciences, Medical School, University of Crete
  • 1990-1996: BSc, Department of Biology, University of Patras

Work Experience 💼:

  • 2023-present: Professor of Pharmacology, Medical School, University of Crete
  • 2018-present: Researcher/Group Leader, Institute of Molecular Biology and Biotechnology (IMBB), FORTH
  • 2021-present: Director, Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden

Skills 🔍

Dr. Charalampopoulos is highly skilled in neuropharmacology, molecular biology techniques, and neurodegenerative disease research. His expertise includes:

  • Neurotrophin receptor structure-function analysis
  • Development of therapeutic ligands for brain regeneration
  • Neurogenesis and neuroprotection strategies
  • Animal models of Alzheimer’s disease and spinal cord injury
  • Human iPSC-derived neural platforms for disease modeling
  • Collaborative research in neuroscience and pharmacology

Awards and Honors 🏆

Dr. Charalampopoulos has received multiple recognitions throughout his career, including prestigious grants for his innovative work in neuroscience and neurodegenerative disease treatment:

  • HORIZON-EIC-2022 European Commission Grant: Coordinating a project on soft-robot-assisted therapeutic delivery for neurological disorders (budget: 2.9 million euros).
  • National Flagship Project: Funding for the elucidation of the genetic basis of Alzheimer’s and Parkinson’s diseases (budget: 610,000 euros).
  • Numerous research accolades, with over 80 publications in peer-reviewed journals (h-index: 35, citations >3000).

🤝 Memberships:

Dr. Charalampopoulos is a member of several prestigious scientific organizations, including:

  • International Society for Neuroscience
  • European Society of Neurochemistry
  • Society for Neuroscience (SfN)
  • Greek Society for Pharmacology

Teaching Experience 👩‍🏫:

Dr. Charalampopoulos has been actively involved in educating future generations of neuroscientists, particularly through his role as the Director of the Graduate Program in Neurosciences at the University of Crete. His teaching experience includes:

  • Undergraduate and postgraduate courses in pharmacology, neuropharmacology, and molecular biology.
  • Mentoring and supervising PhD students and postdoctoral researchers in pharmacology and neuroscience.
  • Developing innovative teaching methods, including the use of human stem cell models in neuroscience research.

Research Focus 🔬:

Dr. Charalampopoulos’ research interests revolve around the molecular mechanisms by which growth factors and their receptors regulate the regenerative capacity of the nervous system. Key areas include:

  • Neurotrophins: Their role in brain development, neurogenesis, neuronal survival, and repair during aging.
  • Neurodegenerative Diseases: Investigating novel therapeutic strategies for Alzheimer’s disease, Parkinson’s disease, and spinal cord injury.
  • Ligand Development: Creating novel ligands targeting neurotrophin receptors to enhance regenerative and neuroprotective effects.
  • Stem Cell Models: Using human induced pluripotent stem cell-derived platforms to test therapeutics for neurodegenerative diseases.
    His ultimate goal is to decipher the signaling mechanisms underlying neurodegeneration and regeneration, leading to the development of novel drugs for brain repair.
Conclusion 

Dr. Ioannis Charalampopoulos is undoubtedly a top contender for the Best Researcher Award. His exceptional contributions to neuroscience, his innovative approaches in neuropharmacology, and his ability to secure substantial research funding demonstrate that he is not only an accomplished researcher but also a transformative figure in the field of neurodegenerative diseases. His strengths lie in the originality of his work, leadership in research initiatives, and mentorship in education. With slight improvements in public outreach, collaborative networks, and clinical translation, he can further elevate his already remarkable career. Therefore, Dr. Charalampopoulos is a highly deserving nominee for the Best Researcher Award, given his outstanding scientific contributions, leadership, and lasting impact on the field of neuroscience.

📚 Publilcation

  • “Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer’s disease”
    • Year: 2024
    • Journal: Frontiers in Cellular Neuroscience
    • Type: Review
    • DOI: 10.3389/fncel.2024.1422130
  • “Editorial: Steroid receptors in neuron and glia”
    • Year: 2024
    • Journal: Frontiers in Endocrinology
    • Type: Editorial
    • DOI: 10.3389/fendo.2024.1472908
  • “Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease”
    • Year: 2024
    • Journal: Stem Cell Research & Therapy
    • Type: Journal Article
    • DOI: 10.1186/s13287-024-03818-w
  • “Cover Image, Volume 72, Issue 4”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24399
  • “Dynamics of myelin deficits in the 5xFAD mouse model for Alzheimer’s disease and the protective role of BDNF”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24505
  • “Multimodal beneficial effects of BNN27, a Nerve Growth Factor synthetic mimetic, in the 5xFAD mouse model of Alzheimer’s Disease”
    • Year: 2024
    • Type: Preprint
    • DOI: 10.21203/rs.3.rs-3886007/v1
  • “Development of Pleiotropic TrkB and 5-HT<sub>4</sub> Receptor Ligands as Neuroprotective Agents”
    • Year: 2024
    • Journal: Molecules
    • Type: Journal Article
    • DOI: 10.3390/molecules29020515
  • “Butanolides and Butenolides from a Marine-Derived Streptomyces sp. Exert Neuroprotective Activity through Activation of the TrkB Neurotrophin Receptor”
    • Year: 2023
    • Journal: Marine Drugs
    • Type: Journal Article
    • DOI: 10.3390/md21090465
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor, Regulating Neuronal Survival in a Cell Context-Dependent Manner”
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
    • Type: Journal Article
    • DOI: 10.3390/ijms241411683
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor Promoting Cell Death in Mouse and Human Neuronal Cells”
    • Year: 2023
    • Type: Preprint
    • DOI: 10.20944/preprints202306.1633.v1

Prof. Dr. binli | Neuroscience | Best Researcher Award

Prof. Dr. binli | Neuroscience | Best Researcher Award 🏆

Lecturer (University Professor) at yangzhou university,China🎓

The nominee, a PhD holder in Architecture since 2016, has demonstrated excellence in research, education, and practical applications in architecture and sustainability. His dual focus on comfort and accessibility, alongside nature-based solutions for climate resilience, addresses critical contemporary issues. His notable contributions, backed by research grants and real-world projects, underscore his commitment to advancing sustainable architecture.

 

Professional Profile 

🎓 Education

Bin Li earned his Ph.D. in Neuroscience from Nanjing Agricultural University, where his master’s thesis was recognized as an excellent thesis. His educational background laid a strong foundation for his expertise in neuroimmunology and endothelial cell research. 🎓🏆

🏢 Work Experience

As a university-appointed professor, Bin has made significant contributions to the field of Neuroscience. His work focuses on the mechanisms of mRNA methylation in endothelial cells and their role in recovery after ischemic stroke, enhancing our understanding of neurovascular repair processes. 🧠🏥

🧬 Skills

  • Bin possesses advanced research skills in molecular biology and neuroimmunology, with a strong capability in conducting complex experiments and data analysis. His ability to communicate complex scientific concepts effectively enhances his teaching and mentorship roles. 🧪📊

Awards and Honors 🏆

He has received numerous accolades, including the “Lv Yang Jin Feng” Outstanding Doctor award and recognition for an outstanding paper at the 19th National Academic Exchange Meeting on Neuropsychopharmacology in 2021. 🥇🎖️

Memberships📜 

Bin is an active member of professional organizations, including the Neuroimmunology Branch of the Jiangsu Society of Immunology and the Basic Veterinary Branch of the Jiangsu Animal Husbandry and Veterinary Association, which facilitate collaboration and knowledge exchange in his field. 🤝🌐

📚 Teaching Experience

In his role as a lecturer, Bin is dedicated to educating the next generation of scientists, fostering a stimulating learning environment, and guiding students through advanced concepts in Neuroscience and immunology. 📖👨‍🏫

🔬 Research Focus

His current research investigates glial cell-to-neuron and endothelial cell inter-communication during post-ischemic injury, aiming to uncover novel therapeutic strategies for brain recovery. With a total of 12 published papers and significant citations, his research is influential in the field. 🔍🧬

Conclusion 

In conclusion, Dr. Bin Li exemplifies the qualities of a leading researcher deserving of the Best Researcher Award. His innovative research, impressive publication record, and active engagement in the scientific community highlight his significant contributions to neuroscience. Addressing the areas for improvement could further amplify his impact, making him a valuable asset to both academia and society. Dr. Li’s commitment to advancing knowledge in neurovascular repair positions him as an outstanding candidate for this prestigious recognition.

📚 Publilcation 

  • EHR coding with hybrid attention and features propagation on disease knowledge graph
    • Year: 2024
    • Journal: Artificial Intelligence in Medicine
  • DAJLENet: A neural network based on dual attention and joint learning for explainable heart failure adverse event prediction
    • Year: 2024
    • Journal: Computers and Electrical Engineering
  • Application programming interface recommendation for smart contract using deep learning from augmented code representation
    • Year: 2024
    • Journal: Journal of Software: Evolution and Process
  • Extraction of Corn Plant Phenotypic Parameters with Keypoint Detection and Stereo Images
    • Year: 2024
    • Journal: Agronomy
  • Ponzi Scheme Detection in Smart Contract via Transaction Semantic Representation Learning
    • Year: 2024
    • Journal: IEEE Transactions on Reliability
  • Normalization of kinship relations to enrich family network analysis: case study on China biographical database
    • Year: 2024
    • Journal: Digital Scholarship in the Humanities
  • Fine-grained smart contract vulnerability detection by heterogeneous code feature learning and automated dataset construction
    • Year: 2024
    • Journal: Journal of Systems and Software
  • Neurodynamics for Equality-Constrained Time-Variant Nonlinear Optimization Using Discretization
    • Year: 2024
    • Journal: IEEE Transactions on Industrial Informatics
  • Automatic software vulnerability classification by extracting vulnerability triggers
    • Year: 2024
    • Journal: Journal of Software: Evolution and Process

 

 

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award 🏆

Division of Diabetes and Nutrition at RARiS, Tohoku University, Japan
🎓

Dr. Katsunori Nonogaki is a distinguished professor and clinical specialist in diabetes and internal medicine, holding extensive expertise in lifestyle medicine and diabetes research. He obtained his MD in Japan in 1987, followed by a PhD from Nagoya University Graduate School of Medicine in 1993. His postdoctoral training included positions at UCSF and The Scripps Research Institute, where he focused on metabolism and neuropharmacology. Dr. Nonogaki has held key academic roles at prestigious institutions, including the University of Tokyo and Tohoku University, where he has been a professor since 2008.

Professional Profile 

📚 Work Experience & Teaching

Dr. Nonogaki has a long-standing academic career, beginning as a lecturer at the University of Tokyo before joining Tohoku University in various professorial roles. His teaching experience spans undergraduate to postgraduate levels, where he mentors future leaders in diabetes research and metabolic health.

🎖️ Skills, Awards, and Honors

Dr. Nonogaki is highly skilled in molecular nutrition, metabolic diseases, and translational research. He has served as the Chief of the Laboratory of Molecular Nutrition and is recognized for his contributions to diabetes research, earning several awards in this domain. He has also made impactful contributions to scientific literature, serving on the editorial boards of key journals such as Frontiers in Endocrinology and Diabetes Research and Clinical Practice.

🌐 Memberships & Professional Involvement

His professional involvement extends to numerous editorial roles, including Topic Editor and Associate Editor in leading journals. Dr. Nonogaki is a highly regarded member of the international diabetes research community, where he actively contributes to advancements in metabolic health and diabetes management.

Research Focus

Xiaofeng’s research is centered on entrepreneurial behavior, project selection, and risk assessment. He has proposed a three-stage theory for project selection and developed a dynamic measurement model for entrepreneurial risks. His work has practical implications, particularly in the evaluation of risks in family farms and entrepreneurship education. His 65 published journal articles and various patents further underscore his contributions to the field.

 

Publications : 

“The GLP-1 Receptor Agonist Liraglutide Decreases Primary Bile Acids and Serotonin in the Colon Independently of Feeding in Mice”
Year: 2024
Journal: International Journal of Molecular Sciences